Patent · US Active

Estrogen replacement regimen

US8946198B2 · kind B2 · utility

0Cited by

11References

5Claims

0Family size

Inventors

Robert Casper · Toronto, CA
Gideon Kopernik · Ramat HaSharon, IL
Zeev Shoham · Ramat HaSharon, IL

Key dates

Filing date	Aug 28, 2003
Grant date	Feb 3, 2015
Priority date	—
Expiry date	Dec 20, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides an improved method to deliver estrogen to menopausal women comprising administering ultra-low dose estradiol alternating with standard-dose estradiol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.